“…It is expressed on the surface of cells of the myeloid lineage, including dendritic cells, neutrophils, monocytes and macrophages, on B lymphocytes (Bates et al, 1999), CD4TL from HIV-1 patients (Lambert et al, 2010) and on CD4 and CD8 T lymphocytes of arthritic patients (Eklow et al, 2008). Previous studies have shown that dendritic cells or apoptotic CD4TL bind HIV-1 via DCIR and that this leads to both trans and cis infection of CD4TL (Lambert et al, 2008(Lambert et al, , 2010. In addition, a series of DCIR inhibitors of small molecular mass have been identified and shown to inhibit HIV-1 interactions with dendritic and CD4TL cells (Lambert et al, 2013).…”